"With expertise
in complex pharmaceutical drug discovery, biomanufacturing,
and electronics manufacturing technologies, our highly trained
analysts investigate markets for high tech business-to-business
products and services. Our custom reports are in-depth analyses
that bring leading edge science together with profitable
business strategies for the pharmaceutical and electronics
industries." William P. Downey, President
New Report Just Published, December 2007
High Throughput Screening 2007:
New Strategies, Success Rates, and Use of Enabling Technologies
This 980-page report documents current HTS practices for drug
discovery, company organizations and the evolving role
of the HTS laboratory in pharmaceutical companies, academic
centers, and institutes worldwide. The study provides
an in-depth analysis of new HTS strategies to increase
success, current and expected use of cell-based assays
and high content screening, equipment used and purchases
planned, targets and target classes growing in importance,
types of assays used and new trends, use of label-free
technologies, the number of compounds screened, throughput,
formats, budgets and expenditures by product category,
market size and growth, and the challenges in HTS for
both users and their suppliers. Published December 2007.
Biopharmaceutical
Contract Manufacturing 2007: Quality,Capacities and Emerging
Technologies
This 800-page
report, the comprehensive 2007 industry report, provides
the latest information on biomanufacturing strategies, new
products and manufacturing efficiencies, expression systems
and cell lines, capacity additions, new equipment including
disposables, challenges ahead for the industry, and expanded
outsourcing services so readers can make the most successful
strategic decisions. The data and the analysis in this report
are based on 68 in-depth interviews conducted with biomanufacturing
directors at pharmaceutical and biotechnology companies
and contractor companies worldwide. It is the most comprehensive
and current industry report on biopharmaceutical contract
manufacturing. Published February 2007.
>>
Details & Order
Biopharmaceutical
Contract Manufacturing:
Best Practices Pricing Study 2006
This 350-page report
documents pricing practices, policies, agreements, and strategies.
Learn what pharmaceutical and biotechnology companies
are paying contractors for mammalian cell culture, microbial
fermentation production, and related services. Per-
batch, per time-in-facility, and per-gram prices are analyzed
by technology and by tank sizes. Both prices paid
and prices charged are documented.
The History
of High Throughput Screening for Drug Discovery:
1998-2005
HighTech Business
Decisions (HTBD) has conducted six market research studies
and published six comprehensive industry reports on high throughput
screening (HTS) since 1998. This report is specifically designed
to understand the changes that have occurred in HTS since
1998, how accurate HTS directors have been in forecasting
and predicting their use of technology and future needs, how
HTS practices have evolved, and the success of HTS as a drug
discovery tool. Topics include the number of disease targets
screened, target types, assay types, detection modes, microplate
formats, outsourcing, and other issues impacting HTS operations
and success. The complete analysis, based on both user and
supplier primary research, includes market size and growth,
major players, user strategies and requirements, documentation
of success in drug discovery, trends and technologies, and
respondents’ perceptions regarding the future of HTS.
Directory of Biopharmaceutical
Contract Manufacturers
The 2007 directory provides a thorough listing
of 79 contractors worldwide, including information on Type of
Services Offered, Equipment Capacity, cGMP Certification by
Service Category and more.
|
